United States Oncology Injection Drug Market Report & Forecast 2021-2027

Publisher Name :
Date: 11-Oct-2021
No. of pages: 106
Inquire Before Buying

United States Oncology Injection Drug Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)

United States Oncology Injection Drug Market Segment Percentages, By Type, 2020 (%)

- Organs

- Central Nervous System

- Circulatory/Musculoskeletal System

- Other

United States Oncology Injection Drug Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)

United States Oncology Injection Drug Market Segment Percentages, By Application, 2020 (%)

- Lymphoma

- Myeloma

- Prostate Cancer

- Other

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Oncology Injection Drug revenues in United States market, 2016-2021 (Estimated), ($ millions)

Key companies Oncology Injection Drug revenues share in United States market, 2020 (%)

Key companies Oncology Injection Drug sales in United States market, 2016-2021 (Estimated), (K Pcs)

Key companies Oncology Injection Drug sales share in United States market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Taj Oncology

- S.G. Biopharm

- AdvaCare

- Merrimack

- Celgene

- Allos Therapeutics

- Ferring Pharmaceuticals

- Genzyme

- Eli Lilly

- Praecis Pharmaceuticals

- Millennium Pharmaceuticals

- Debiopharm

- Alza

- CordenPharma

- Pharmascience

United States Oncology Injection Drug Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Oncology Injection Drug Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Oncology Injection Drug Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Oncology Injection Drug Overall Market Size
2.1 United States Oncology Injection Drug Market Size: 2021 VS 2027
2.2 United States Oncology Injection Drug Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Oncology Injection Drug Sales: 2016-2027
3 Company Landscape
3.1 Top Oncology Injection Drug Players in United States Market
3.2 Top United States Oncology Injection Drug Companies Ranked by Revenue
3.3 United States Oncology Injection Drug Revenue by Companies
3.4 United States Oncology Injection Drug Sales by Companies
3.5 United States Oncology Injection Drug Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Oncology Injection Drug Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Oncology Injection Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Oncology Injection Drug Players in United States Market
3.8.1 List of Tier 1 Oncology Injection Drug Companies in United States
3.8.2 List of Tier 2 and Tier 3 Oncology Injection Drug Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Oncology Injection Drug Market Size Markets, 2021 & 2027
4.1.2 Organs
4.1.3 Central Nervous System
4.1.4 Circulatory/Musculoskeletal System
4.1.5 Other
4.2 By Type - United States Oncology Injection Drug Revenue & Forecasts
4.2.1 By Type - United States Oncology Injection Drug Revenue, 2016-2021
4.2.2 By Type - United States Oncology Injection Drug Revenue, 2022-2027
4.2.3 By Type - United States Oncology Injection Drug Revenue Market Share, 2016-2027
4.3 By Type - United States Oncology Injection Drug Sales & Forecasts
4.3.1 By Type - United States Oncology Injection Drug Sales, 2016-2021
4.3.2 By Type - United States Oncology Injection Drug Sales, 2022-2027
4.3.3 By Type - United States Oncology Injection Drug Sales Market Share, 2016-2027
4.4 By Type - United States Oncology Injection Drug Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Oncology Injection Drug Market Size, 2021 & 2027
5.1.2 Lymphoma
5.1.3 Myeloma
5.1.4 Prostate Cancer
5.1.5 Other
5.2 By Application - United States Oncology Injection Drug Revenue & Forecasts
5.2.1 By Application - United States Oncology Injection Drug Revenue, 2016-2021
5.2.2 By Application - United States Oncology Injection Drug Revenue, 2022-2027
5.2.3 By Application - United States Oncology Injection Drug Revenue Market Share, 2016-2027
5.3 By Application - United States Oncology Injection Drug Sales & Forecasts
5.3.1 By Application - United States Oncology Injection Drug Sales, 2016-2021
5.3.2 By Application - United States Oncology Injection Drug Sales, 2022-2027
5.3.3 By Application - United States Oncology Injection Drug Sales Market Share, 2016-2027
5.4 By Application - United States Oncology Injection Drug Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Taj Oncology
6.1.1 Taj Oncology Corporation Information
6.1.2 Taj Oncology Overview
6.1.3 Taj Oncology Oncology Injection Drug Sales and Revenue in United States Market (2016-2021)
6.1.4 Taj Oncology Oncology Injection Drug Product Description
6.1.5 Taj Oncology Recent Developments
6.2 S.G. Biopharm
6.2.1 S.G. Biopharm Corporation Information
6.2.2 S.G. Biopharm Overview
6.2.3 S.G. Biopharm Oncology Injection Drug Sales and Revenue in United States Market (2016-2021)
6.2.4 S.G. Biopharm Oncology Injection Drug Product Description
6.2.5 S.G. Biopharm Recent Developments
6.3 AdvaCare
6.3.1 AdvaCare Corporation Information
6.3.2 AdvaCare Overview
6.3.3 AdvaCare Oncology Injection Drug Sales and Revenue in United States Market (2016-2021)
6.3.4 AdvaCare Oncology Injection Drug Product Description
6.3.5 AdvaCare Recent Developments
6.4 Merrimack
6.4.1 Merrimack Corporation Information
6.4.2 Merrimack Overview
6.4.3 Merrimack Oncology Injection Drug Sales and Revenue in United States Market (2016-2021)
6.4.4 Merrimack Oncology Injection Drug Product Description
6.4.5 Merrimack Recent Developments
6.5 Celgene
6.5.1 Celgene Corporation Information
6.5.2 Celgene Overview
6.5.3 Celgene Oncology Injection Drug Sales and Revenue in United States Market (2016-2021)
6.5.4 Celgene Oncology Injection Drug Product Description
6.5.5 Celgene Recent Developments
6.6 Allos Therapeutics
6.6.1 Allos Therapeutics Corporation Information
6.6.2 Allos Therapeutics Overview
6.6.3 Allos Therapeutics Oncology Injection Drug Sales and Revenue in United States Market (2016-2021)
6.6.4 Allos Therapeutics Oncology Injection Drug Product Description
6.6.5 Allos Therapeutics Recent Developments
6.7 Ferring Pharmaceuticals
6.7.1 Ferring Pharmaceuticals Corporation Information
6.7.2 Ferring Pharmaceuticals Overview
6.7.3 Ferring Pharmaceuticals Oncology Injection Drug Sales and Revenue in United States Market (2016-2021)
6.7.4 Ferring Pharmaceuticals Oncology Injection Drug Product Description
6.7.5 Ferring Pharmaceuticals Recent Developments
6.8 Genzyme
6.8.1 Genzyme Corporation Information
6.8.2 Genzyme Overview
6.8.3 Genzyme Oncology Injection Drug Sales and Revenue in United States Market (2016-2021)
6.8.4 Genzyme Oncology Injection Drug Product Description
6.8.5 Genzyme Recent Developments
6.9 Eli Lilly
6.9.1 Eli Lilly Corporation Information
6.9.2 Eli Lilly Overview
6.9.3 Eli Lilly Oncology Injection Drug Sales and Revenue in United States Market (2016-2021)
6.9.4 Eli Lilly Oncology Injection Drug Product Description
6.9.5 Eli Lilly Recent Developments
6.10 Praecis Pharmaceuticals
6.10.1 Praecis Pharmaceuticals Corporation Information
6.10.2 Praecis Pharmaceuticals Overview
6.10.3 Praecis Pharmaceuticals Oncology Injection Drug Sales and Revenue in United States Market (2016-2021)
6.10.4 Praecis Pharmaceuticals Oncology Injection Drug Product Description
6.10.5 Praecis Pharmaceuticals Recent Developments
6.11 Millennium Pharmaceuticals
6.11.1 Millennium Pharmaceuticals Corporation Information
6.11.2 Millennium Pharmaceuticals Overview
6.11.3 Millennium Pharmaceuticals Oncology Injection Drug Sales and Revenue in United States Market (2016-2021)
6.11.4 Millennium Pharmaceuticals Oncology Injection Drug Product Description
6.11.5 Millennium Pharmaceuticals Recent Developments
6.12 Debiopharm
6.12.1 Debiopharm Corporation Information
6.12.2 Debiopharm Overview
6.12.3 Debiopharm Oncology Injection Drug Sales and Revenue in United States Market (2016-2021)
6.12.4 Debiopharm Oncology Injection Drug Product Description
6.12.5 Debiopharm Recent Developments
6.13 Alza
6.13.1 Alza Corporation Information
6.13.2 Alza Overview
6.13.3 Alza Oncology Injection Drug Sales and Revenue in United States Market (2016-2021)
6.13.4 Alza Oncology Injection Drug Product Description
6.13.5 Alza Recent Developments
6.14 CordenPharma
6.14.1 CordenPharma Corporation Information
6.14.2 CordenPharma Overview
6.14.3 CordenPharma Oncology Injection Drug Sales and Revenue in United States Market (2016-2021)
6.14.4 CordenPharma Oncology Injection Drug Product Description
6.14.5 CordenPharma Recent Developments
6.15 Pharmascience
6.15.1 Pharmascience Corporation Information
6.15.2 Pharmascience Overview
6.15.3 Pharmascience Oncology Injection Drug Sales and Revenue in United States Market (2016-2021)
6.15.4 Pharmascience Oncology Injection Drug Product Description
6.15.5 Pharmascience Recent Developments
7 United States Oncology Injection Drug Production Capacity, Analysis
7.1 United States Oncology Injection Drug Production Capacity, 2016-2027
7.2 Oncology Injection Drug Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Oncology Injection Drug Supply Chain Analysis
9.1 Oncology Injection Drug Industry Value Chain
9.2 Oncology Injection Drug Upstream Market
9.3 Oncology Injection Drug Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Oncology Injection Drug Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Oncology Injection Drug in United States Market
Table 2. Top Oncology Injection Drug Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Oncology Injection Drug Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Oncology Injection Drug Revenue Share by Companies, 2016-2021
Table 5. United States Oncology Injection Drug Sales by Companies, (K Pcs), 2016-2021
Table 6. United States Oncology Injection Drug Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Oncology Injection Drug Price (2016-2021) & (USD/Pcs)
Table 8. Manufacturers Oncology Injection Drug Product Type
Table 9. List of Tier 1 Oncology Injection Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Oncology Injection Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Organs
Table 12. Major Manufacturers of Central Nervous System
Table 13. By Type - United States Oncology Injection Drug Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Oncology Injection Drug Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Oncology Injection Drug Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Oncology Injection Drug Sales (K Pcs), 2016-2021
Table 17. By Type - United States Oncology Injection Drug Sales (K Pcs), 2022-2027
Table 18. By Application - United States Oncology Injection Drug Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Oncology Injection Drug Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Oncology Injection Drug Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Oncology Injection Drug Sales (K Pcs), 2016-2021
Table 22. By Application - United States Oncology Injection Drug Sales (K Pcs), 2022-2027
Table 23. Taj Oncology Corporation Information
Table 24. Taj Oncology Description and Major Businesses
Table 25. Taj Oncology Oncology Injection Drug Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 26. Taj Oncology Oncology Injection Drug Product
Table 27. Taj Oncology Recent Developments
Table 28. S.G. Biopharm Corporation Information
Table 29. S.G. Biopharm Description and Major Businesses
Table 30. S.G. Biopharm Oncology Injection Drug Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 31. S.G. Biopharm Oncology Injection Drug Product
Table 32. S.G. Biopharm Recent Developments
Table 33. AdvaCare Corporation Information
Table 34. AdvaCare Description and Major Businesses
Table 35. AdvaCare Oncology Injection Drug Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 36. AdvaCare Oncology Injection Drug Product
Table 37. AdvaCare Recent Developments
Table 38. Merrimack Corporation Information
Table 39. Merrimack Description and Major Businesses
Table 40. Merrimack Oncology Injection Drug Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 41. Merrimack Oncology Injection Drug Product
Table 42. Merrimack Recent Developments
Table 43. Celgene Corporation Information
Table 44. Celgene Description and Major Businesses
Table 45. Celgene Oncology Injection Drug Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 46. Celgene Oncology Injection Drug Product
Table 47. Celgene Recent Developments
Table 48. Allos Therapeutics Corporation Information
Table 49. Allos Therapeutics Description and Major Businesses
Table 50. Allos Therapeutics Oncology Injection Drug Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 51. Allos Therapeutics Oncology Injection Drug Product
Table 52. Allos Therapeutics Recent Developments
Table 53. Ferring Pharmaceuticals Corporation Information
Table 54. Ferring Pharmaceuticals Description and Major Businesses
Table 55. Ferring Pharmaceuticals Oncology Injection Drug Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 56. Ferring Pharmaceuticals Oncology Injection Drug Product
Table 57. Ferring Pharmaceuticals Recent Developments
Table 58. Genzyme Corporation Information
Table 59. Genzyme Description and Major Businesses
Table 60. Genzyme Oncology Injection Drug Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 61. Genzyme Oncology Injection Drug Product
Table 62. Genzyme Recent Developments
Table 63. Eli Lilly Corporation Information
Table 64. Eli Lilly Description and Major Businesses
Table 65. Eli Lilly Oncology Injection Drug Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 66. Eli Lilly Oncology Injection Drug Product
Table 67. Eli Lilly Recent Developments
Table 68. Praecis Pharmaceuticals Corporation Information
Table 69. Praecis Pharmaceuticals Description and Major Businesses
Table 70. Praecis Pharmaceuticals Oncology Injection Drug Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 71. Praecis Pharmaceuticals Oncology Injection Drug Product
Table 72. Praecis Pharmaceuticals Recent Developments
Table 73. Millennium Pharmaceuticals Corporation Information
Table 74. Millennium Pharmaceuticals Description and Major Businesses
Table 75. Millennium Pharmaceuticals Oncology Injection Drug Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 76. Millennium Pharmaceuticals Oncology Injection Drug Product
Table 77. Millennium Pharmaceuticals Recent Developments
Table 78. Debiopharm Corporation Information
Table 79. Debiopharm Description and Major Businesses
Table 80. Debiopharm Oncology Injection Drug Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 81. Debiopharm Oncology Injection Drug Product
Table 82. Debiopharm Recent Developments
Table 83. Alza Corporation Information
Table 84. Alza Description and Major Businesses
Table 85. Alza Oncology Injection Drug Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 86. Alza Oncology Injection Drug Product
Table 87. Alza Recent Developments
Table 88. CordenPharma Corporation Information
Table 89. CordenPharma Description and Major Businesses
Table 90. CordenPharma Oncology Injection Drug Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 91. CordenPharma Oncology Injection Drug Product
Table 92. CordenPharma Recent Developments
Table 93. Pharmascience Corporation Information
Table 94. Pharmascience Description and Major Businesses
Table 95. Pharmascience Oncology Injection Drug Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 96. Pharmascience Oncology Injection Drug Product
Table 97. Pharmascience Recent Developments
Table 98. Oncology Injection Drug Production Capacity (K Pcs) of Key Manufacturers in United States Market, 2019-2021 (K Pcs)
Table 99. United States Oncology Injection Drug Capacity Market Share of Key Manufacturers, 2019-2021
Table 100. Oncology Injection Drug Market Opportunities & Trends in United States Market
Table 101. Oncology Injection Drug Market Drivers in United States Market
Table 102. Oncology Injection Drug Market Restraints in United States Market
Table 103. Oncology Injection Drug Raw Materials
Table 104. Oncology Injection Drug Raw Materials Suppliers in United States Market
Table 105. Typical Oncology Injection Drug Downstream
Table 106. Oncology Injection Drug Downstream Clients in United States Market
Table 107. Oncology Injection Drug Distributors and Sales Agents in United States Market
List of Figures
Figure 1. Oncology Injection Drug Product Picture
Figure 2. Oncology Injection Drug Segment by Type
Figure 3. Oncology Injection Drug Segment by Application
Figure 4. United States Oncology Injection Drug Market Overview: 2020
Figure 5. United States Oncology Injection Drug Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Oncology Injection Drug Revenue, 2016-2027 (US$, Mn)
Figure 7. Oncology Injection Drug Sales in United States Market: 2016-2027 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Oncology Injection Drug Revenue in 2020
Figure 9. Organs Product Picture
Figure 10. Central Nervous System Product Picture
Figure 11. Circulatory/Musculoskeletal System Product Picture
Figure 12. Other Product Picture
Figure 13. By Type - United States Oncology Injection Drug Sales Market Share, 2016-2027
Figure 14. By Type - United States Oncology Injection Drug Revenue Market Share, 2016-2027
Figure 15. By Type - United States Oncology Injection Drug Price (USD/Pcs), 2016-2027
Figure 16. Lymphoma
Figure 17. Myeloma
Figure 18. Prostate Cancer
Figure 19. Other
Figure 20. By Application - United States Oncology Injection Drug Sales Market Share, 2016-2027
Figure 21. By Application - United States Oncology Injection Drug Revenue Market Share, 2016-2027
Figure 22. By Application - United States Oncology Injection Drug Price (USD/Pcs), 2016-2027
Figure 23. Taj Oncology Oncology Injection Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. S.G. Biopharm Oncology Injection Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. AdvaCare Oncology Injection Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Merrimack Oncology Injection Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Celgene Oncology Injection Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Allos Therapeutics Oncology Injection Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Ferring Pharmaceuticals Oncology Injection Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. Genzyme Oncology Injection Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. Eli Lilly Oncology Injection Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. Praecis Pharmaceuticals Oncology Injection Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. Millennium Pharmaceuticals Oncology Injection Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 34. Debiopharm Oncology Injection Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 35. Alza Oncology Injection Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 36. CordenPharma Oncology Injection Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 37. Pharmascience Oncology Injection Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. United States Oncology Injection Drug Production Capacity (K Pcs), 2016-2027
Figure 39. Oncology Injection Drug Industry Value Chain
Figure 40. Marketing Channels
  • China Ocular Drug Delivery Market Report & Forecast 2021-2027
    Published: 26-Oct-2021        Price: US 3400 Onwards        Pages: 91
    China Ocular Drug Delivery Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Doses) China Ocular Drug Delivery Market Segment Percentages, By Type, 2020 (%) - Ocular Insert - Iontophoresis - Intraocular Implants - In Situ Gel & Punctal Plugs - Others China Ocular Drug Delivery Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Doses) China Ocular Drug Delivery Market Segment Percentages, By Application, 2020 (%)......
  • China Nuclear Medicine/Radiopharmaceutic Market Report & Forecast 2021-2027
    Published: 26-Oct-2021        Price: US 3400 Onwards        Pages: 93
    China Nuclear Medicine/Radiopharmaceutic Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (Kiloton) China Nuclear Medicine/Radiopharmaceutic Market Segment Percentages, By Type, 2020 (%) - Tc-99 - I-123/131 - In-111 - Xe-133 - Th-201 - Ga-67 - Other China Nuclear Medicine/Radiopharmaceutic Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (Kiloton) China Nuclear Medicine/Radiopharmaceutic Market Segment P......
  • China NSAIDs Market Report & Forecast 2021-2027
    Published: 26-Oct-2021        Price: US 3400 Onwards        Pages: 90
    China NSAIDs Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) China NSAIDs Market Segment Percentages, By Type, 2020 (%) - Aspirin - Ibuprofen - Naproxen - Nabumetone - Others China NSAIDs Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) China NSAIDs Market Segment Percentages, By Application, 2020 (%) - Back Pain Treatment - Osteoarthritis Treatment - Other Disease Treatment......
  • China Non-Tyrosine Kinase Inhibitors Market Report & Forecast 2021-2027
    Published: 26-Oct-2021        Price: US 3400 Onwards        Pages: 107
    China Non-Tyrosine Kinase Inhibitors Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) China Non-Tyrosine Kinase Inhibitors Market Segment Percentages, By Type, 2020 (%) - mTOR Inhibitors - RAF/MEK Inhibitors - CDK Inhibitors China Non-Tyrosine Kinase Inhibitors Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) China Non-Tyrosine Kinase Inhibitors Market Segment Percentages, By Application, 2020 (%) - Liver Can......
  • China Nonsteroidal Antiinflammatory Drugs Market Report & Forecast 2021-2027
    Published: 26-Oct-2021        Price: US 3400 Onwards        Pages: 90
    China Nonsteroidal Antiinflammatory Drugs Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) China Nonsteroidal Antiinflammatory Drugs Market Segment Percentages, By Type, 2020 (%) - Oral Nonsteroidal Antiinflammatory Drugs - Injection Nonsteroidal Antiinflammatory Drugs China Nonsteroidal Antiinflammatory Drugs Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) China Nonsteroidal Antiinflammatory Drugs Market Segment Percenta......
  • China Non-opioid Pain Patch Market Report & Forecast 2021-2027
    Published: 26-Oct-2021        Price: US 3400 Onwards        Pages: 107
    China Non-opioid Pain Patch Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (M Units) China Non-opioid Pain Patch Market Segment Percentages, By Type, 2020 (%) - Lidocaine Patches - Diclofenac Patches - Indomethacin Patches - Counter-Irritant Patches - Fentanyl Patches - Others China Non-opioid Pain Patch Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (M Units) China Non-opioid Pain Patch Market Segment Perc......
  • China Non Narcotic Analgesics Market Report & Forecast 2021-2027
    Published: 26-Oct-2021        Price: US 3400 Onwards        Pages: 92
    China Non Narcotic Analgesics Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) China Non Narcotic Analgesics Market Segment Percentages, By Type, 2020 (%) - Non Steroid Antiinflammatory Drug - Steroid Antiinflammatory Drug China Non Narcotic Analgesics Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) China Non Narcotic Analgesics Market Segment Percentages, By Application, 2020 (%) - Hospital - Medical Center......
  • Global Azelastine Nasal Spray Market Research Report 2021
    Published: 26-Oct-2021        Price: US 2900 Onwards        Pages: 100
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - 0.137MG/SPRAY - 0.2055MG/SPRAY - Other Segment by Application - Hospital - Ret......
  • Global Azelastine Drug Market Research Report 2021
    Published: 26-Oct-2021        Price: US 2900 Onwards        Pages: 114
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Nasal Spray - Eye Drops - Other Segment by Application - Hospital - Retail Pha......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs